San Diego, CA, United States of America

David I-Chun Lee

This inventor holds 7 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Dexcom, Inc.. Active years: 2019-2024.

USPTO Granted Patents = 7 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 9.9

ph-index = 3

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovator Spotlight: David I-Chun Lee - Revolutionizing Sensor Calibration

Introduction:

David I-Chun Lee, based in San Diego, CA, is a prolific inventor in the field of sensor technology, holding an impressive total of 7 patents. His groundbreaking work at Dexcom, Inc. has been instrumental in advancing sensor calibration methodologies.

Latest Patents:

1. System and method for factory calibration or reduced calibration of an indwelling sensor based on sensitivity profile and baseline model of sensors: Lee's innovative system involves predictive modeling of sensor behavior and physiology to achieve factory calibration, ensuring consistent sensitivity determination.

2. Automatic analyte sensor calibration and error detection: This patent addresses the frequent need for sensor calibration by providing a preconnected analyte sensor system, enhancing recognition of the sensor environment over time for improved calibration.

Career Highlights:

David I-Chun Lee's career highlights include spearheading the development of cutting-edge sensor technologies at Dexcom, Inc., leading to significant advancements in sensor calibration accuracy and efficiency.

Collaborations:

Collaborating closely with talented professionals such as Rui Ma and Jonathan Hughes, Lee has successfully integrated diverse expertise to drive innovation and excellence in sensor calibration technologies.

Conclusion:

In conclusion, David I-Chun Lee's remarkable contributions to sensor calibration through his patented inventions reflect his unwavering commitment to advancing healthcare technologies. His work stands as a testament to the power of innovation and collaboration in transforming the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…